Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6982470

CC(C)C[C@@H](C(=O)NN(CC(C)C)C(=O)C[C@H](N)C(=O)O)[C@H](CC=Cc1ccccc1)C(=O)NO.O=C(O)C(F)(F)F

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 2/20 0.58
GRIK1 P39086 10/20 0.41
GRIK2 Q13002 10/20 0.41
MMP2 P08253 7/20 0.38
MMP3 P08254 7/20 0.38
MMP7 P09237 6/20 0.38
MMP1 P03956 5/20 0.37
MMP8 P22894 2/20 0.37
MMP9 P14780 1/20 0.37
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
MMP14 P50281 1/20 0.37
FCER2 P06734 1/20 0.35
CTSC P53634 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6982462 1.00 ADAM17 (0.58) ADAM17GRIK1GRIK2MMP2MMP3
Trifluoroacetic Acid SCHEMBL6982454 1.00 ADAM17 (0.58) ADAM17GRIK1GRIK2MMP2MMP3
Trifluoroacetic Acid SCHEMBL6985843 0.88 ADAM17 (0.60) ADAM17GRIK1GRIK2MMP2MMP3
Trifluoroacetic Acid SCHEMBL7813087 0.88 ADAM17 (0.55) ADAM17GRIK1GRIK2MMP2MMP3
SCHEMBL6937771 0.87 ADAM17 (0.69) ADAM17MMP2MMP3MMP7MMP1
Trifluoroacetic Acid SCHEMBL6986139 0.85 ADAM17 (0.59) ADAM17GRIK1GRIK2MMP2MMP3
SCHEMBL6943851 0.85 ADAM17 (0.67) ADAM17MMP2MMP3MMP7MMP1
SCHEMBL6986418 0.84 ADAM17 (0.70) ADAM17MMP2MMP3MMP7MMP1
Hydrochloric Acid SCHEMBL6986409 0.82 ADAM17 (0.68) ADAM17GRIK1GRIK2MMP2MMP3
Hydrochloric Acid SCHEMBL6984718 0.82 ADAM17 (0.68) ADAM17GRIK1GRIK2MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089964-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed